Moxifloxacin (Zion Therapeutics)

N/A

Report date: 2025/01/26 17:18:31
NME

Base Information

Drug NameMoxifloxacin (Zion Therapeutics)
Drug Alias NameZimoxinmoxifloxacin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA gyrase degradersTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsEndophthalmitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZion Therapeutics, LLC
China Registration ClassN/A

Develop Information

Active CompaniesZion Therapeutics, LLC
Inactive CompaniesN/A
Active IndicationsEndophthalmitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A